ACTINIUM PHARMACEUTICALS, INC. (ATNM) Net income 2016–2025
ACTINIUM PHARMACEUTICALS, INC. (ATNM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$33.9MFY2025 · since FY2016: -$24.3M → -$33.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.9M | +11.4% |
| FY2024 | -$38.2M | +21.7% |
| FY2023 | -$48.8M | -47.9% |
| FY2022 | -$33.0M | -33.3% |
| FY2021 | -$24.8M | -11.5% |
| FY2020 | -$22.2M | -1.4% |
| FY2019 | -$21.9M | +7.4% |
| FY2018 | -$23.7M | +11.1% |
| FY2017 | -$26.6M | -9.4% |
| FY2016 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice